Active Ingredient History
Platelet-rich plasma (PRP), also known as autologous conditioned plasma, is a concentrate of platelet-rich plasma protein derived from whole blood, centrifuged to remove red blood cells. Though promoted to treat an array of medical problems, evidence for benefit is mixed as of 2020, with some evidence for use in certain conditions and against use in other conditions. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Achilles Tendon (Phase 4)
Acne Vulgaris (Phase 3)
Airway Extubation (Phase 1/Phase 2)
Alopecia (Phase 4)
Alopecia Areata (Phase 4)
Alveolar Bone Loss (Phase 2/Phase 3)
Amenorrhea (Phase 2/Phase 3)
Anterior Cruciate Ligament Injuries (Phase 4)
Arthritis (Phase 4)
Arthritis, Rheumatoid (Phase 1)
Arthroplasty (Early Phase 1)
Athletic Injuries (Phase 1)
Atrophic Vaginitis (Phase 1)
Back Injuries (Phase 4)
Back Pain (Phase 4)
Blood Platelets (Phase 4)
Breast Neoplasms (Phase 4)
Bruxism (Phase 2/Phase 3)
Bursitis (Early Phase 1)
Carpal Tunnel Syndrome (Phase 3)
Cartilage Diseases (Phase 4)
Cesarean Section (Phase 2)
Chronic Disease (Phase 2)
Chronic Pain (Phase 4)
Cicatrix, Hypertrophic (Phase 2)
Cleft Lip (Phase 2)
Corneal Diseases (Phase 4)
COVID-19 (Phase 1/Phase 2)
Cystitis, Interstitial (Phase 1/Phase 2)
Dental Implantation (Phase 3)
Dermatology (Phase 1/Phase 2)
Diabetes, Gestational (Phase 2/Phase 3)
Diabetes Mellitus (Phase 2/Phase 3)
Diabetes Mellitus, Type 1 (Phase 1/Phase 2)
Diabetic Foot (Phase 3)
Diabetic Retinopathy (Phase 2)
Dry Eye Syndromes (Phase 4)
Elbow (Phase 4)
Elbow Tendinopathy (Phase 4)
Endoscopic Mucosal Resection (Phase 3)
Erectile Dysfunction (Phase 2/Phase 3)
Facial Injuries (Phase 3)
Fasciitis, Plantar (Phase 4)
Fat Body (Phase 2/Phase 3)
Fecal Incontinence (Early Phase 1)
Female (Phase 2)
Femoracetabular Impingement (Phase 4)
Fissure in Ano (Phase 4)
Genital Diseases, Male (Phase 2)
Graft vs Host Disease (Phase 1)
Gynatresia (Phase 2)
Headache (Phase 1)
Hyaluronic Acid (Phase 4)
Infant, Premature (Phase 1)
Infections (Phase 4)
Infertility (Phase 4)
Infertility, Female (Phase 2/Phase 3)
Intervertebral Disc Degeneration (Phase 3)
Joint Diseases (Phase 2)
Knee Injuries (Phase 4)
Lichen Planus (Phase 2)
Lipids (Phase 2/Phase 3)
Low Back Pain (Phase 4)
Melanosis (Phase 3)
Meniscus (Phase 4)
Menopause (Phase 2/Phase 3)
Menopause, Premature (Phase 2/Phase 3)
Menstrual Cycle (Phase 2/Phase 3)
Muscles (Phase 3)
Myalgia (Phase 2/Phase 3)
Neck Pain (Phase 2/Phase 3)
Neuralgia (Phase 1)
Osteoarthritis (Phase 4)
Osteoarthritis, Hip (Phase 3)
Osteoarthritis, Knee (Phase 4)
Otitis Media (Phase 2/Phase 3)
Ovarian Diseases (Phase 2/Phase 3)
Pain (Phase 4)
Pelvic Floor Disorders (Phase 2/Phase 3)
Pemphigus (Phase 3)
Penile Induration (Phase 2)
Peptic Ulcer (Phase 1/Phase 2)
Platelet-Rich Plasma (Phase 4)
Pneumothorax (Phase 1/Phase 2)
Popliteal Cyst (Phase 3)
Postmenopause (Phase 1)
Pregnancy Outcome (Phase 2)
Primary Ovarian Insufficiency (Phase 2/Phase 3)
Rectal Fistula (Phase 4)
Respiratory Distress Syndrome (Phase 1/Phase 2)
Rotator Cuff Injuries (Phase 4)
Sacroiliitis (Phase 4)
Sexual Dysfunction, Physiological (Phase 2)
Shoulder Injuries (Phase 3)
Shoulder Pain (Phase 1)
Sjogren's Syndrome (Phase 3)
Skin Aging (Phase 1/Phase 2)
Spinal Cord Injuries (Phase 1)
Sprains and Strains (Phase 4)
Temporomandibular Joint Disorders (Phase 2/Phase 3)
Tendinopathy (Phase 3)
Tennis Elbow (Phase 3)
Therapeutics (Phase 4)
Tissue Adhesions (Phase 2)
Tooth Abnormalities (Phase 4)
Tooth Loss (Phase 2/Phase 3)
Traumatology (Phase 1)
Tympanic Membrane Perforation (Phase 2/Phase 3)
Ultrasonography (Phase 4)
Urinary Incontinence (Phase 2/Phase 3)
Urinary Incontinence, Stress (Phase 2/Phase 3)
Vaginitis (Phase 1)
Varicose Ulcer (Phase 3)
Vulvar Lichen Sclerosus (Phase 2)
Wound Healing (Phase 2)
Wounds and Injuries (Phase 2/Phase 3)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue